Citation Impact
Citing Papers
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
5 Treatment and prognostic factors in acute myeloid leukaemia
1996
Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons
1997 Standout
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial
2015
Hydroxychloroquine for the treatment of chronic graft-versus-host disease
2000
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Risk of bladder cancer in foundry workers: a meta-analysis
2002
Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease?
2004
Pulmonary Outcomes in Survivors of Childhood Cancer
2011
Interferons and Their Stimulated Genes in the Tumor Microenvironment
2014
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Multiple myeloma
2000 Standout
Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial
2002 Standout
Non‐endocrine late complications of bone marrow transplantation in childhood: part II
2002
Impact of previous high-dose therapy on outcome after allografting for multiple myeloma
1999
Chronic graft-versus-host disease
2003 Standout
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Long-Term Results of Autologous Stem Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s Lymphoma
2006
Salvage autologous or allogeneic transplantation for multiple myeloma refractory to or relapsing after a first-line autograft?
1998
Hematopoietic Stem-Cell Transplantation
2006 Standout
A review of airborne polycyclic aromatic hydrocarbons (PAHs) and their human health effects
2013 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an eastern cooperative oncology group trial (E4995)
2004
Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation
2004
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Bladder cancer: Epidemiology, staging and grading, and diagnosis
2005 Standout
Retroviral transduction of human dihydropyrimidine dehydrogenase cDNA confers resistance to 5-fluorouracil in murine hematopoietic progenitor cells and human CD34+-enriched peripheral blood progenitor cells
2001
Pancreatic cancer in industrial branches and occupations in finland
1994
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation
2001
Mitoxantrone
1996
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
2002 Standout
The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia
2017
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Acute Myeloid Leukemia
2015 Standout
Health Effects of Chronic Pesticide Exposure: Cancer and Neurotoxicity
2004 Standout
Graft-versus-leukemia reactions after bone marrow transplantation
1990 Standout
Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age
2001
Host Reactive Donor T Cells Are Associated With Lung Injury After Experimental Allogeneic Bone Marrow Transplantation
1998
Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants
2003
Meta-analysis of Hodgkin's disease among farmers
1999
Immune Interventions in Disease
1987
Conversion of Alloantigen-Specific CD8+ T Cell Anergy to CD8+ T Cell Priming through In Vivo Ligation of Glucocorticoid-Induced TNF Receptor
2006 StandoutNobel
Treatment of the Newly Diagnosed Adult with De Noyo Acute Myeloid Leukemia
1993
Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome
1996
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
1998 Standout
Integrating Genetic Approaches into the Discovery of Anticancer Drugs
1997 StandoutScienceNobel
Host Reactive Donor T Cells Are Associated With Lung Injury After Experimental Allogeneic Bone Marrow Transplantation
1998
A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study
1996
Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.
1993
Sense and nonsense of high-dose cytarabine for acute myeloid leukemia
2013
CI-973, a new platinum derivative with potential antileukemic activity.
1992
Works of JJ Spinelli being referenced
High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adults
1991
Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy [see comments]
1994
Treatment of myeloma using intensive therapy and allogeneic bone marrow transplantation.
1995
Effect of lymphoblastoid interferon on lymphocyte subsets in cancer patients.
1983
Obstructive lung disease in children after allogeneic bone marrow transplantation
1994
Occupational associations among British Columbia male cancer patients.
1990
High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adults
1991
Obstructive lung disease in children after allogeneic bone marrow transplantation
1994